GSK3B and breast carcinoma: Moreover, the data from breast cancer research indicated that expression of p-AKT and p-GSK-3β dramatically decreased in breast cancer cells upon DACT2 re-expression, which indicated DACT2 might regulate Akt/GSK-3 signaling pathway to involve in migration and invasion 83.